JW Holdings Participates in International Pharmaceutical Expo 'CPhl'... "Targeting Global Market"

[Asia Economy Reporter Seo So-jeong] JW Holdings announced on the 4th that it will participate in the international pharmaceutical exhibition 'CPhI Worldwide 2021,' held for three days from the 9th (local time) in Milan, Italy, showcasing JW Group's key pharmaceuticals such as infusion solutions and antibiotics, as well as healthcare products to the global market.

CPhI Worldwide is the world's largest pharmaceutical exhibition, held annually in major cities around the world. It serves as a global exchange platform among healthcare companies, covering not only raw materials and finished pharmaceuticals but also pharmaceutical packaging, equipment, and logistics sectors.

JW Holdings will set up an independent booth in the FDF (Finished Dosage Form) exhibition hall to display pharmaceuticals and healthcare products. In the pharmaceutical zone, it will introduce the 3-chamber total parenteral nutrition solution Winnerf and carbapenem-class antibiotics.

Winnerf is a product composed of four lipid components, glucose, and amino acids. Compared to existing total parenteral nutrition solutions, it contains a higher amount of refined fish oil with omega-3 and omega-6 fatty acids, which helps enhance patients' immunity and promote recovery. JW Life Science has been exporting this product to the European market since 2018 and signed a technology transfer and supply contract for the Chinese market last year.

They will also showcase carbapenem-class antibiotics, the next-generation antibiotics following penicillin and cephalosporins. JW Pharmaceutical succeeded in developing the first generic imipenem in 2004 and has since succeeded in synthesizing raw materials for meropenem, ertapenem, and doripenem, establishing the only full production portfolio of carbapenem antibiotics in Korea. In June, India's Grand Pharma launched a finished product in the U.S. market using JW Pharmaceutical's ertapenem raw materials. This is the first case of domestically produced carbapenem antibiotic raw materials entering the U.S. market.

In the healthcare zone, JW Pharmaceutical's premium wound care band 'HiMom' product line, JW Shinyak's male hair loss treatment 'MyDilac,' JW Life Health's skincare solution 'Ringsel,' HA filler 'Initium,' and other major healthcare products from subsidiaries will be exhibited. Additionally, JW Holdings will unveil the scalp and hair care brand 'Polinique,' which it recently formed a strategic partnership with the smart optical tech company IEL Science to supply to the global market.

A JW Holdings official said, "This year's CPhI is attracting more attention as an important event for pioneering export markets, as the exhibition is held both online and offline, unlike last year's online-only event due to COVID-19." He added, "We will actively promote JW's excellent products and production infrastructure to overseas buyers."